The Journal of Experimental Medicine · 2014 · 80 citations · 46 references
Life SciencesImmunologyInfectious DiseasesAdaptive ImmunityImmunotherapyMolecular VirologyAdaptive Immune ResponsesAntiretroviral TherapyAntiviral ImmunityAntiviral TherapyViral Immune EvasionViral InfectionsAntibody-mediated Viral NeutralizationAntibody-mediated Virus NeutralizationAntigen Escape VariantsAntiviral ImmunotherapyBroadly Neutralizing Antibody TargetingHost Immune Response ModulationViral Escape MutationsViral Immune Evasion Mechanisms
Antibody-mediated immunotherapy is effective in humanized mice when combinations of broadly neutralizing antibodies (bNAbs) are used that target nonoverlapping sites on the human immunodeficiency virus type 1 (HIV-1) envelope. In contrast, single bNAbs can control simian-human immunodeficiency virus (SHIV) infection in immune-competent macaques, suggesting that the host immune response might also contribute to the control of viremia. Here, we investigate how the autologous antibody response in intact hosts can contribute to the success of immunotherapy. We find that frequently arising antibodies that normally fail to control HIV-1 infection can synergize with passively administered bNAbs by preventing the emergence of bNAb viral escape variants.
46
Antibody neutralization and escape by HIV-1
Xiping Wei, Julie M. Decker, Shuyi Wang et al. · Nature · 2003 · 2.4K citations
Broad neutralization coverage of HIV by multiple highly potent antibodies
Laura M. Walker, Michael Huber, Katie J. Doores et al. · Nature · 2011 · 1.5K citations
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Johannes F. Scheid, Hugo Mouquet, Beatrix Ueberheide et al. · Science · 2011 · 1.2K citations · Full text
Ming Li, Feng Gao, John R. Mascola et al. · Journal of Virology · 2005 · 1.1K citations · Full text